Clinical Trials

Showing trials with last updates posted in 2024.

NCT02420912 | COMPLETED | PHASE2
37 participants

Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-20
Start Date:
2015-06-19
Completion:
2022-02-14
Conditions
  • Loss of Chromosome 17p
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
  • Richter Syndrome
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT06319235 | RECRUITING | PHASE1/PHASE2
52 participants

Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-19
Start Date:
2023-10-27
Completion:
2025-12-31
Conditions
  • Surgical Site Infection
  • Staphylococcus Aureus Infection
  • Pseudomonas Aeruginosa Infection
  • Bacterial Infections
  • Surgical Wound Infection
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page